Aspiriant LLC’s S&P Global SPGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$444K Buy
1,091
+219
+25% +$92.5K 0.01% 264
2026
Q1
$371K Buy
+872
New +$405K 0.01% 251
2025
Q3
Sell
-422
Closed -$223K 318
2025
Q2
$223K Sell
422
-65
-13% -$32.4K 0.01% 292
2025
Q1
$247K Sell
487
-3
-0.6% -$1.53K 0.01% 262
2024
Q4
$244K Buy
490
+96
+24% +$48.7K 0.01% 259
2024
Q3
$204K Buy
+394
New +$195K 0.01% 284
2024
Q2
Sell
-934
Closed -$397K 323
2024
Q1
$397K Buy
934
+30
+3% +$13K 0.02% 219
2023
Q4
$398K Buy
+904
New +$357K 0.02% 212
2020
Q2
Sell
-1,199
Closed -$295K 195
2020
Q1
$295K Buy
+1,199
New +$329K 0.03% 159

Other funds holding SPGI

Aspiriant LLC's SPGI Position: Q2 2026 in Review

Aspiriant LLC increased its S&P Global (SPGI) stake by 25% in Q2 2026, buying an estimated $92.5K and bringing the position to 1,091 shares worth $444K. The position accounts for 0.01% of the portfolio, ranked #264.

Aspiriant LLC first reported a position in SPGI in Q1 2020 and has held it in 9 quarters since. 2,012 funds tracked by Wall St. Rank hold SPGI as of Q2 2026.

  • Aspiriant LLC held 1,091 shares of S&P Global worth $444K as of Q2 2026.
  • Aspiriant LLC bought 219 S&P Global shares in Q2 2026, an estimated $92.5K.
  • S&P Global made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #264 holding.
  • Aspiriant LLC first reported a position in S&P Global in Q1 2020 and has held it in 9 quarters since.
  • 2,012 funds tracked by Wall St. Rank held S&P Global as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.